{"id":395291,"date":"2020-12-08T08:33:33","date_gmt":"2020-12-08T13:33:33","guid":{"rendered":"http:\/\/www.marketnewsdesk.com\/?p=395291"},"modified":"2020-12-08T08:33:33","modified_gmt":"2020-12-08T13:33:33","slug":"alimera-sciences-to-present-at-the-13th-annual-ld-micro-main-event-virtual-conference","status":"publish","type":"post","link":"https:\/\/www.marketnewsdesk.com\/index.php\/alimera-sciences-to-present-at-the-13th-annual-ld-micro-main-event-virtual-conference\/","title":{"rendered":"Alimera Sciences to Present at the 13th Annual LD Micro Main Event Virtual Conference"},"content":{"rendered":"<div class=\"mw_release\">\n<p>ATLANTA, Dec.  08, 2020  (GLOBE NEWSWIRE) &#8212; Alimera Sciences, Inc. (Nasdaq: ALIM) (Alimera), a leader in the commercialization and development of prescription ophthalmology treatments for the management of retinal diseases, today announces that CEO Rick Eiswirth will present a corporate overview at the 13th Annual LD Micro Main Event virtual investor conference on Monday, December 14 at 8:20 AM PST\/11:20 AM EST. The format will be a 10-minute presentation followed by a 10-minute Q&amp;A session with a panel of investors and analysts.<\/p>\n<p>Interested participants can register to view the presentation and Q&amp;A session at <a href=\"https:\/\/www.globenewswire.com\/Tracker?data=fp4jZTaNmIQO_yqpON8uwxNiMpPRq2g3NuBvl9PsOk83JpC_aldkhghgVK14e-KKt-JGxSg86OgxmAPL6v4nbA==\" rel=\"nofollow noopener noreferrer\" target=\"_blank\">ve.mysequire.com\/<\/a><\/p>\n<p>View Alimera Sciences\u2019 LD Micro profile <a href=\"https:\/\/www.globenewswire.com\/Tracker?data=ylQ_rcBPk70E0IRu1IIpScTgRnxB2RHp-yw-iOX6TpaqH7mPBbpXngg7JbgoLz2qdz3i8tJj6-av88JZjIaLYg==\" rel=\"nofollow noopener noreferrer\" target=\"_blank\">here<\/a>.<\/p>\n<p>\n        <strong>About Alimera Sciences, Inc.<\/strong>\n      <\/p>\n<p>Alimera Sciences is a pharmaceutical company that specializes in the commercialization and development of prescription ophthalmic pharmaceuticals. Alimera is presently focused on diseases affecting the back of the eye, or retina, because these diseases are not well treated with current therapies and affect millions of people in our aging populations. For more information, please visit <a href=\"https:\/\/www.globenewswire.com\/Tracker?data=wHcs_ARMKuP9ShEjIG0ucwwERU-_a56scfGmAKvyU0fCo5lhrYMfmRl5QmGFwaa_NwOLOVRQTp_O80NXYM40J7vzqTofL612VpAFzVFfeVQ=\" rel=\"nofollow noopener noreferrer\" target=\"_blank\">www.alimerasciences.com<\/a>.<\/p>\n<p>\n        <strong>About LD Micro\/SEQUIRE<\/strong><\/p>\n<p>LD Micro began in 2006 with the sole purpose of being an independent resource to the microcap world. What started as a newsletter highlighting unique companies, transformed into a prominent event platform in the space. For more information, please visit <a href=\"https:\/\/www.globenewswire.com\/Tracker?data=Af2v1cKn9pgx3iAohOQcrrwBIdHB35XvDUxoFUcR6ROGdwDmQUZnsLfUa9jGUJQ44rSKRIH9XSIWBvsgwYFdeg==\" rel=\"nofollow noopener noreferrer\" target=\"_blank\">ldmicro.com<\/a>.<\/p>\n<table style=\"border-collapse: collapse;width:100%;border-collapse:collapse\">\n<tr>\n<td style=\"vertical-align: top\">\n            <strong>For press inquiries:<\/strong><br \/>\n            <br \/>Jules Abraham<br \/>for Alimera Sciences <br \/>917-885-7378<br \/>julesa@coreir.com<\/td>\n<td style=\"vertical-align: middle;text-align: left;padding-left: 30.0px;vertical-align: top\">\n            <strong>For investor inquiries:<\/strong><br \/>\n            <br \/>Scott Gordon<br \/>for Alimera Sciences<br \/>scottg@coreir.com<\/td>\n<\/tr>\n<\/table>\n<p>      <img loading=\"lazy\" decoding=\"async\" class=\"__GNW8366DE3E__IMG\" src=\"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODA5ODIxNSMzODYwNTYxIzIwMDQwMTM=\" width=\"1\" height=\"1\" \/><br \/>\n      <br \/>\n      <img loading=\"lazy\" decoding=\"async\" class=\"__GNW8366DE3E__IMG\" src=\"https:\/\/ml.globenewswire.com\/release\/track\/ee94f903-dc8e-49cc-9b67-e51cee734e71\" width=\"1\" height=\"1\" \/>\n    <\/div>\n<div class=\"mw_contactinfo\"><\/div>\n","protected":false},"excerpt":{"rendered":"<p>ATLANTA, Dec. 08, 2020 (GLOBE NEWSWIRE) &#8212; Alimera Sciences, Inc. (Nasdaq: ALIM) (Alimera), a leader in the commercialization and development of prescription ophthalmology treatments for the management of retinal diseases, today announces that CEO Rick Eiswirth will present a corporate overview at the 13th Annual LD Micro Main Event virtual investor conference on Monday, December 14 at 8:20 AM PST\/11:20 AM EST. The format will be a 10-minute presentation followed by a 10-minute Q&amp;A session with a panel of investors and analysts. Interested participants can register to view the presentation and Q&amp;A session at ve.mysequire.com\/ View Alimera Sciences\u2019 LD Micro profile here. About Alimera Sciences, Inc. Alimera Sciences is a pharmaceutical company that specializes in the commercialization and development of &hellip; <\/p>\n<p class=\"link-more\"><a href=\"https:\/\/www.marketnewsdesk.com\/index.php\/alimera-sciences-to-present-at-the-13th-annual-ld-micro-main-event-virtual-conference\/\" class=\"more-link\">Continue reading<span class=\"screen-reader-text\"> &#8220;Alimera Sciences to Present at the 13th Annual LD Micro Main Event Virtual Conference&#8221;<\/span><\/a><\/p>\n","protected":false},"author":2,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[],"tags":[],"class_list":["post-395291","post","type-post","status-publish","format-standard","hentry"],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v27.4 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>Alimera Sciences to Present at the 13th Annual LD Micro Main Event Virtual Conference - Market Newsdesk<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.marketnewsdesk.com\/index.php\/alimera-sciences-to-present-at-the-13th-annual-ld-micro-main-event-virtual-conference\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Alimera Sciences to Present at the 13th Annual LD Micro Main Event Virtual Conference - Market Newsdesk\" \/>\n<meta property=\"og:description\" content=\"ATLANTA, Dec. 08, 2020 (GLOBE NEWSWIRE) &#8212; Alimera Sciences, Inc. (Nasdaq: ALIM) (Alimera), a leader in the commercialization and development of prescription ophthalmology treatments for the management of retinal diseases, today announces that CEO Rick Eiswirth will present a corporate overview at the 13th Annual LD Micro Main Event virtual investor conference on Monday, December 14 at 8:20 AM PST\/11:20 AM EST. The format will be a 10-minute presentation followed by a 10-minute Q&amp;A session with a panel of investors and analysts. Interested participants can register to view the presentation and Q&amp;A session at ve.mysequire.com\/ View Alimera Sciences\u2019 LD Micro profile here. About Alimera Sciences, Inc. Alimera Sciences is a pharmaceutical company that specializes in the commercialization and development of &hellip; Continue reading &quot;Alimera Sciences to Present at the 13th Annual LD Micro Main Event Virtual Conference&quot;\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.marketnewsdesk.com\/index.php\/alimera-sciences-to-present-at-the-13th-annual-ld-micro-main-event-virtual-conference\/\" \/>\n<meta property=\"og:site_name\" content=\"Market Newsdesk\" \/>\n<meta property=\"article:published_time\" content=\"2020-12-08T13:33:33+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODA5ODIxNSMzODYwNTYxIzIwMDQwMTM=\" \/>\n<meta name=\"author\" content=\"Newsdesk\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Newsdesk\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"1 minute\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/alimera-sciences-to-present-at-the-13th-annual-ld-micro-main-event-virtual-conference\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/alimera-sciences-to-present-at-the-13th-annual-ld-micro-main-event-virtual-conference\\\/\"},\"author\":{\"name\":\"Newsdesk\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"headline\":\"Alimera Sciences to Present at the 13th Annual LD Micro Main Event Virtual Conference\",\"datePublished\":\"2020-12-08T13:33:33+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/alimera-sciences-to-present-at-the-13th-annual-ld-micro-main-event-virtual-conference\\\/\"},\"wordCount\":246,\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/alimera-sciences-to-present-at-the-13th-annual-ld-micro-main-event-virtual-conference\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=ODA5ODIxNSMzODYwNTYxIzIwMDQwMTM=\",\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/alimera-sciences-to-present-at-the-13th-annual-ld-micro-main-event-virtual-conference\\\/\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/alimera-sciences-to-present-at-the-13th-annual-ld-micro-main-event-virtual-conference\\\/\",\"name\":\"Alimera Sciences to Present at the 13th Annual LD Micro Main Event Virtual Conference - Market Newsdesk\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/alimera-sciences-to-present-at-the-13th-annual-ld-micro-main-event-virtual-conference\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/alimera-sciences-to-present-at-the-13th-annual-ld-micro-main-event-virtual-conference\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=ODA5ODIxNSMzODYwNTYxIzIwMDQwMTM=\",\"datePublished\":\"2020-12-08T13:33:33+00:00\",\"author\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"breadcrumb\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/alimera-sciences-to-present-at-the-13th-annual-ld-micro-main-event-virtual-conference\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/alimera-sciences-to-present-at-the-13th-annual-ld-micro-main-event-virtual-conference\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/alimera-sciences-to-present-at-the-13th-annual-ld-micro-main-event-virtual-conference\\\/#primaryimage\",\"url\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=ODA5ODIxNSMzODYwNTYxIzIwMDQwMTM=\",\"contentUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=ODA5ODIxNSMzODYwNTYxIzIwMDQwMTM=\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/alimera-sciences-to-present-at-the-13th-annual-ld-micro-main-event-virtual-conference\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Alimera Sciences to Present at the 13th Annual LD Micro Main Event Virtual Conference\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\",\"name\":\"Market Newsdesk\",\"description\":\"Latest Business News in Real Time\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\",\"name\":\"Newsdesk\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"contentUrl\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"caption\":\"Newsdesk\"},\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/author\\\/newsdesk\\\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Alimera Sciences to Present at the 13th Annual LD Micro Main Event Virtual Conference - Market Newsdesk","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.marketnewsdesk.com\/index.php\/alimera-sciences-to-present-at-the-13th-annual-ld-micro-main-event-virtual-conference\/","og_locale":"en_US","og_type":"article","og_title":"Alimera Sciences to Present at the 13th Annual LD Micro Main Event Virtual Conference - Market Newsdesk","og_description":"ATLANTA, Dec. 08, 2020 (GLOBE NEWSWIRE) &#8212; Alimera Sciences, Inc. (Nasdaq: ALIM) (Alimera), a leader in the commercialization and development of prescription ophthalmology treatments for the management of retinal diseases, today announces that CEO Rick Eiswirth will present a corporate overview at the 13th Annual LD Micro Main Event virtual investor conference on Monday, December 14 at 8:20 AM PST\/11:20 AM EST. The format will be a 10-minute presentation followed by a 10-minute Q&amp;A session with a panel of investors and analysts. Interested participants can register to view the presentation and Q&amp;A session at ve.mysequire.com\/ View Alimera Sciences\u2019 LD Micro profile here. About Alimera Sciences, Inc. Alimera Sciences is a pharmaceutical company that specializes in the commercialization and development of &hellip; Continue reading \"Alimera Sciences to Present at the 13th Annual LD Micro Main Event Virtual Conference\"","og_url":"https:\/\/www.marketnewsdesk.com\/index.php\/alimera-sciences-to-present-at-the-13th-annual-ld-micro-main-event-virtual-conference\/","og_site_name":"Market Newsdesk","article_published_time":"2020-12-08T13:33:33+00:00","og_image":[{"url":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODA5ODIxNSMzODYwNTYxIzIwMDQwMTM=","type":"","width":"","height":""}],"author":"Newsdesk","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Newsdesk","Est. reading time":"1 minute"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/alimera-sciences-to-present-at-the-13th-annual-ld-micro-main-event-virtual-conference\/#article","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/alimera-sciences-to-present-at-the-13th-annual-ld-micro-main-event-virtual-conference\/"},"author":{"name":"Newsdesk","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"headline":"Alimera Sciences to Present at the 13th Annual LD Micro Main Event Virtual Conference","datePublished":"2020-12-08T13:33:33+00:00","mainEntityOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/alimera-sciences-to-present-at-the-13th-annual-ld-micro-main-event-virtual-conference\/"},"wordCount":246,"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/alimera-sciences-to-present-at-the-13th-annual-ld-micro-main-event-virtual-conference\/#primaryimage"},"thumbnailUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODA5ODIxNSMzODYwNTYxIzIwMDQwMTM=","inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/alimera-sciences-to-present-at-the-13th-annual-ld-micro-main-event-virtual-conference\/","url":"https:\/\/www.marketnewsdesk.com\/index.php\/alimera-sciences-to-present-at-the-13th-annual-ld-micro-main-event-virtual-conference\/","name":"Alimera Sciences to Present at the 13th Annual LD Micro Main Event Virtual Conference - Market Newsdesk","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/#website"},"primaryImageOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/alimera-sciences-to-present-at-the-13th-annual-ld-micro-main-event-virtual-conference\/#primaryimage"},"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/alimera-sciences-to-present-at-the-13th-annual-ld-micro-main-event-virtual-conference\/#primaryimage"},"thumbnailUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODA5ODIxNSMzODYwNTYxIzIwMDQwMTM=","datePublished":"2020-12-08T13:33:33+00:00","author":{"@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"breadcrumb":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/alimera-sciences-to-present-at-the-13th-annual-ld-micro-main-event-virtual-conference\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.marketnewsdesk.com\/index.php\/alimera-sciences-to-present-at-the-13th-annual-ld-micro-main-event-virtual-conference\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/alimera-sciences-to-present-at-the-13th-annual-ld-micro-main-event-virtual-conference\/#primaryimage","url":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODA5ODIxNSMzODYwNTYxIzIwMDQwMTM=","contentUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODA5ODIxNSMzODYwNTYxIzIwMDQwMTM="},{"@type":"BreadcrumbList","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/alimera-sciences-to-present-at-the-13th-annual-ld-micro-main-event-virtual-conference\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/www.marketnewsdesk.com\/"},{"@type":"ListItem","position":2,"name":"Alimera Sciences to Present at the 13th Annual LD Micro Main Event Virtual Conference"}]},{"@type":"WebSite","@id":"https:\/\/www.marketnewsdesk.com\/#website","url":"https:\/\/www.marketnewsdesk.com\/","name":"Market Newsdesk","description":"Latest Business News in Real Time","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.marketnewsdesk.com\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Person","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979","name":"Newsdesk","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","caption":"Newsdesk"},"url":"https:\/\/www.marketnewsdesk.com\/index.php\/author\/newsdesk\/"}]}},"_links":{"self":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/395291","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/comments?post=395291"}],"version-history":[{"count":0,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/395291\/revisions"}],"wp:attachment":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/media?parent=395291"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/categories?post=395291"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/tags?post=395291"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}